Cecilia Anna Wilhelmina Geuijen

Cecilia Anna Wilhelmina Geuijen

Chief Tech/Sci/R&D Officer chez MERUS N.V.

56 ans
Consumer Services
Health Technology

Provenance du réseau au premier degré de Cecilia Anna Wilhelmina Geuijen

EntitéType d'entitéIndustrie
Public Company Biotechnology 19

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Cecilia Anna Wilhelmina Geuijen via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Pharmaceuticals: Major

Bill Lundberg

Chief Tech/Sci/R&D Officer

Biotechnology

Len Kanavy

Corporate Officer/Principal

ALEXION PHARMACEUTICALS, INC. Pharmaceuticals: Major

Bill Lundberg

Corporate Officer/Principal

Medical Specialties

Bill Lundberg

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Antisoma Research Ltd.

Bill Lundberg

Corporate Officer/Principal

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

KALA BIO, INC. Pharmaceuticals: Major

Gregory Perry

Mark Iwicki

Director/Board Member

Chief Executive Officer

Biotechnology

Mark Iwicki

Director/Board Member

ACLARIS THERAPEUTICS, INC. Pharmaceuticals: Major

Maxine Gowen

Anand Mehra

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

Investment Managers

Mark Iwicki

Consultant / Advisor

Massachusetts Institute of Technology College/University

Bill Lundberg

Andrew Joe

Undergraduate Degree

Undergraduate Degree

College/University

Sherri L. Spear

Undergraduate Degree

Ithaca College College/University

Shannon Campbell

Undergraduate Degree

Loyola University Maryland, Inc. College/University

Mark Iwicki

Masters Business Admin

University of Scranton College/University

Len Kanavy

Masters Business Admin

Pharmaceuticals: Major

Mark Iwicki

Corporate Officer/Principal

University of Utrecht College/University

John de Kruif

Doctorate Degree

Icahn School of Medicine at Mount Sinai College/University

Andrew Joe

Graduate Degree

Investment Banks/Brokers

Sherri L. Spear

Analyst-Equity

Biotechnology

Mark Iwicki

Chief Executive Officer

Stanford University School of Medicine College/University

Bill Lundberg

Doctorate Degree

AIMMUNE THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

CRISPR THERAPEUTICS AG Biotechnology

Bill Lundberg

Chief Tech/Sci/R&D Officer

Philadelphia College of Pharmacy College/University

Ashley Pereira

Graduate Degree

PULMATRIX, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

Pharmaceuticals: Major

Mark Iwicki

Director/Board Member

BLACK DIAMOND THERAPEUTICS, INC. Biotechnology

Shannon Campbell

Director/Board Member

VOR BIOPHARMA INC. Biotechnology

Bill Lundberg

Director/Board Member

Pharmaceuticals: Major

Len Kanavy

Corporate Officer/Principal

Biotechnology

Mark Iwicki

Bill Lundberg

Chairman

Director/Board Member

THIRD HARMONIC BIO, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

AEROVATE THERAPEUTICS, INC. Biotechnology

Mark Iwicki

Director/Board Member

AKERO THERAPEUTICS, INC. Pharmaceuticals: Major

Mark Iwicki

Chairman

RALLYBIO CORPORATION Biotechnology

Liu Hui

Director/Board Member

Genentech Access To Care Foundation

Len Kanavy

Director/Board Member

Statistiques

Internationale

Etats-Unis 40
Pays-Bas 4
Royaume-Uni 4
Suisse 2

Sectorielle

Health Technology 28
Consumer Services 9
Finance 8
Commercial Services 3

Opérationnelle

Director/Board Member 70
Corporate Officer/Principal 36
Independent Dir/Board Member 36
Director of Finance/CFO 12
Undergraduate Degree 12